Insight journal - Company

Actavis: M&A activity 2005-2013

Posted on 03 September 2013

Actavis and Watson together have announced over 30 M&A deals since 2005, with some of the deals being the acquisition of Warner Chilcott, ANDRx and Actavis itself by Watson.

Abstracted from: Partnering Agreements with Actavis (formerly Watson Pharmaceuticals) 2005-2013.

Some of the acquisitions by Actavis Inc. include :

  • Actavis
  • Warner Chilcott
  • ANDRx
  • Arrow Group
  • Specifar Pharma
  • Amide Pharmaceutical
  • Abrika Pharmaceutical

 

For the entire list and full details on each deal can be found at CurrentAgreements (subscription required)

The following figure shows the level of Actavis M&A deal announcements since 2005.

Figure 1: Actavis M&A deals 2005-2013

Actavis M and A deals per year

Source: Current Agreements, 2013

These strategic acquisitions were made to enhance Actavis’s generic and branded product pipeline in CNS and metabolic therapeutics areas.

View full details of the acquisitions at Current Agreements (subscription required)

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Actavis (formerly Watson Pharmaceuticals) 2005-2013

Actavis M&A deals at Current Agreements

View all partnering deals for Actavis:  2013 | 2012 | 2011 | 20102009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Actavis (formerly Watson Pharmaceuticals) 2005-2013                

 

More

Summary profile data for Actavis

Partnering interests for Actavis

Partnering activity for Actavis

 

Available reports from Current Partnering

Report: Partnering Agreements with Actavis (formerly Watson Pharmaceuticals) 2005-2013

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

 

Available resources for deal coverage for Actavis

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Actavis / Watson company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
e80banner300x150animgif
a1banner300x150animgif